Developing new treatment regimens for HIV
European Pharmaceutical Review
MARCH 11, 2024
Having a strong focus on recruiting diverse clinical trial participants along with additional implementation science studies can help industry bridge the gap between research findings and delivery of these different options. But that in itself is not enough when considering the spectrum of populations that require these medicines.
89 
Let's personalize your content